Glucotrack, Inc. (GCTK) stock
GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –
Glucotrack revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Glucotrack's revenue for the twelve months ending Sep 30, 2020 was $70.02K, down 50.1% year over year. For fiscal 2019 it was $208.00K, up 378.3% from the year before. The highest annual figure on record is $611.69K in fiscal 2016.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $208.00K | +378.3% |
| FY2018 | Dec 31, 2018 | $43.49K | -92.6% |
| FY2017 | Dec 31, 2017 | $589.46K | -3.6% |
| FY2016 | Dec 31, 2016 | $611.69K | +327.3% |
| FY2015 | Dec 31, 2015 | $143.17K | +139.5% |
| FY2014 | Dec 31, 2014 | $59.78K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $97 | -99.9% |
| Q1 FY2020 | Mar 31, 2020 | $2.17K | -91.5% |
| Q4 FY2019 | Dec 31, 2019 | $67.75K | – |
| Q3 FY2019 | Sep 30, 2019 | $4.18K | – |
| Q2 FY2019 | Jun 30, 2019 | $110.52K | +623.3% |
| Q1 FY2019 | Mar 31, 2019 | $25.56K | -9.4% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $15.28K | +74.7% |
| Q1 FY2018 | Mar 31, 2018 | $28.21K | -70.7% |
| Q4 FY2017 | Dec 31, 2017 | $463.58K | +257.9% |
| Q3 FY2017 | Sep 30, 2017 | $20.90K | +85.0% |
| Q2 FY2017 | Jun 30, 2017 | $8.74K | – |
| Q1 FY2017 | Mar 31, 2017 | $96.24K | – |
| Q4 FY2016 | Dec 31, 2016 | $129.51K | – |
| Q3 FY2016 | Sep 30, 2016 | $11.30K | – |
See a number that looks wrong?